Financial News · Live Terminal

Page 32 of 193

UBS Adjusts Price Target on Veracyte to $52 From $48, Maintains Buy Rating

Veracyte (VCYT) has an average rating of overweight and mean price target of $47.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $37.50, Change: $+4.53, Percent Change: +13.74%

$VCYT

Australia3d ago

Needham Adjusts Price Target on TransMedics Group to $142 From $174, Maintains Buy Rating

TransMedics Group (TMDX) has an average rating of overweight and mean price target of $121.10, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $75.21, Change: $-19.72, Percent Change: -20.77%

$TMDX

Australia3d ago

Berenberg Adjusts Price Target on Rapid7 to $7.50 From $12, Maintains Hold Rating

Rapid7 (RPD) has an average rating of hold and mean price target of $7.59, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $6.61, Change: $-0.07, Percent Change: -1.05%

$RPD

Australia3d ago

UBS Adjusts Price Target on UL Solutions to $110 From $90, Maintains Neutral Rating

UL Solutions (ULS) has an average rating of overweight and mean price target of $108.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $104.94, Change: $+0.20, Percent Change: +0.19%

$ULS

Australia3d ago

Barrington Adjusts Price Target on Cimpress to $113 From $95, Maintains Outperform Rating

Price: $92.61, Change: $+0.78, Percent Change: +0.85%

$CMPR

Australia3d ago

Barrington Adjusts Price Target on LeMaitre Vascular to $120 From $105, Maintains Outperform Rating

LeMaitre Vascular (LMAT) has an average rating of overweight and mean price target of $117, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $106.04, Change: $-5.96, Percent Change: -5.32%

$LMAT

Australia3d ago

UBS Adjusts Price Target on Skyworks Solutions to $75 From $63, Maintains Neutral Rating

Skyworks Solutions (SWKS) has an average rating of hold and mean price target of $70.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $63.50, Change: $-9.06, Percent Change: -12.49%

$SWKS

Australia3d ago

UBS Adjusts Price Target on Qorvo to $100 From $87, Maintains Neutral Rating

Qorvo (QRVO) has an average rating of hold and mean price target of $90.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.82, Change: $-8.53, Percent Change: -8.85%

$QRVO

Australia3d ago

Novavax Shares Rise After Narrower-Than-Expected Q1 Net Loss

Novavax (NVAX) shares were up over 8% in Wednesday trading after the company swung to a narrower-than-expected Q1 net loss.The company reported it swung to a Q1 net loss of $0.06 per diluted share from net income of $2.93 a year earlier.Analysts polled by FactSet expected a loss of $0.24.Revenue for the quarter ended March 31 was $139.5 million, down from $666.7 million a year earlier.A comparable FactSet estimate was not available.Price: $8.78, Change: $+0.67, Percent Change: +8.20%

$NVAX

Australia3d ago

UBS Adjusts Price Target on Teradata to $34 From $36, Maintains Neutral Rating

Teradata (TDC) has an average rating of overweight and mean price target of $34.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $27.35, Change: $-2.74, Percent Change: -9.10%

$TDC

Australia3d ago

UroGen Pharma Shares Rise on Narrower Q1 Net Loss, Higher Revenue

UroGen Pharma (URGN) shares were up 9.9% in early trading on Wednesday after the company posted a narrower net loss and higher revenue for Q1.The company reported a Q1 net loss of $0.47 per diluted share, narrower than a loss of $0.92 a year earlier.Analysts polled by FactSet expected a loss of $0.48.Revenue for the quarter ended March 31 was $51 million, up from $20.3 million a year earlier.Analysts expected revenue of $44.8 million.As of March 31, the company said it had $140.3 million in cash, cash equivalents and marketable securities on hand.Price: $26.25, Change: $+2.42, Percent Change: +10.16%

$URGN

Australia3d ago

Criteo Shares Fall After Q1 Adjusted Earnings, Revenue Decrease

Criteo (CRTO) shares were down about 16% in early Wednesday trading after the company posted lower Q1 adjusted earnings and revenue.The company reported Q1 adjusted earnings of $0.73 per diluted share, down from $1.10 a year earlier.Analysts surveyed by FactSet expected $0.57.Revenue for the quarter ended March 31 was $424.6 million, down from $451.4 million a year earlier.Price: $16.91, Change: $-3.21, Percent Change: -15.95%

$CRTO

Australia3d ago

UBS Adjusts Price Target on PayPal to $48 From $44, Maintains Neutral Rating

PayPal (PYPL) has an average rating of hold and mean price target of $50.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $46.80, Change: $+0.32, Percent Change: +0.69%

$PYPL

Australia3d ago

UBS Adjusts Price Target on Solventum to $78 From $82, Maintains Neutral Rating

Solventum (SOLV) has an average rating of hold and mean price target of $82.36, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $71.77, Change: $+2.71, Percent Change: +3.93%

$SOLV

Australia3d ago

UBS Adjusts Price Target on Match to $38 From $34, Maintains Neutral Rating

Match (MTCH) has an average rating of overweight and mean price target of $39.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $36.62, Change: $-1.04, Percent Change: -2.75%

$MTCH

Australia3d ago

UBS Adjusts Price Target on Revolve Group to $28 From $31, Maintains Neutral Rating

Revolve Group, Inc (RVLV) has an average rating of overweight and mean price target of $29.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $21.84, Change: $-1.61, Percent Change: -6.87%

$RVLV

Australia3d ago

UBS Adjusts Price Target on Shopify to $130 From $145, Maintains Neutral Rating

Price: $108.26, Change: $+0.64, Percent Change: +0.60%

$SHOP

Australia3d ago

Geron Shares Fall After Reporting Q1 Results

Geron (GERN) shares fell 2.7% in early Wednesday trading after the company reported a Q1 net loss of $0.01 per diluted share, narrowing from a loss of $0.03 a year earlier.Analysts surveyed by FactSet expected a loss of $0.02.Revenue for the quarter ended March 31 was $51.8 million, compared with $39.4 million a year earlier.Analysts surveyed by FactSet expected $50.6 million.Price: $1.61, Change: $-0.04, Percent Change: -2.73%

$GERN

Australia3d ago

UBS Adjusts Price Target on Lumen Technologies to $8 From $6, Maintains Neutral Rating

Lumen Technologies (LUMN) has an average rating of hold and mean price target of $7.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $8.72, Change: $-0.48, Percent Change: -5.22%

$LUMN

Australia3d ago

UBS Adjusts Price Target on Lumentum Holdings to $960 From $455, Maintains Neutral Rating

Lumentum Holdings (LITE) has an average rating of overweight and mean price target of $1,075.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $1000.12, Change: $+5.56, Percent Change: +0.56%

$LITE

Showing 621-640 of 3847